The company leading the race to develop a coronavirus vaccine announced “positive” early findings on Monday, with participants producing antibodies to ward off the disease, NY Post has reported.


The company, Biotech company Moderna Inc. dosed 45 patients between the ages of 18 and 55 with 25, 100 or 250 micrograms of its experimental drug.

Also Read:  Police Officer Who Opened Fire On His Colleagues Showed Signs Of Mental Depression- Lagos Police Command


After receiving a second booster shot, those at the 25 and 100 dosage levels were found with antibody levels that were equal to or exceeded those found in patients who recovered from the COVID-19, the company said in a press release.

Also Read:  Police Arrests Surgeon For Murdering His Wife After Her Remains Were Found Near Their Home


Moderna CEO Stephane Bancel told Bloomberg that the results “couldn’t have been better.”

“This is a very good sign that we make an antibody that can stop the virus from replicating,” he said.

Also Read:  Governor Ikpeazu's Two Aides Test Positive


The experimental vaccine, mRNA-1273, was found to be “generally safe and well tolerated” among patients, the company said. Further testing will begin in July.


Moderna stock soared 26 percent in pre-market trading Monday.

Comment On This Post Here

This site uses Akismet to reduce spam. Learn how your comment data is processed.